Medicus Pharma (MDCX) Stock Price

Medicus Pharma Price

CLOSED
3.25
​
Market closed

Analysts set a median price target of 12.24 USD, implying 276.6% above the current price. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus.

Medicus Pharma stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medicus Pharma business model & stock analysis

Medicus Pharma Ltd, headquartered in Toronto, Ontario, is a clinical stage, multi-strategy holding company focused on investing in novel life sciences and biotechnology companies through FDA-approved clinical trials. The company identifies, acquires, and advances de-risked clinical stage assets via development and commercialization, exploring pipeline expansion through acquisitions and partnerships. Its subsidiary, SkinJect, Inc., develops a novel dissolvable microneedle array drug delivery system for treating basal cell and squamous cell carcinoma, offering a minimally invasive solution for non-melanoma skin cancers.

Frequently asked questions about Medicus Pharma

Analysts currently set an average price target of 12.24 USD for the Medicus Pharma stock (median: 12.24 USD), implying +276.6 % versus the latest price. The consensus is based on 8 analyst ratings.

10 analysts currently rate the Medicus Pharma stock: 9 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Medicus Pharma share trades at 2.90 EUR (3.25 USD).

The revenue cannot currently be calculated for Medicus Pharma.

The expected profit of Medicus Pharma is -13.56 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Medicus Pharma is currently -6.03. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Medicus Pharma stock.

The P/S cannot be calculated for Medicus Pharma currently.

The Eulerpool Quality Score for Medicus Pharma is 2/10.

The ISIN of Medicus Pharma is CA58471K2020. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Medicus Pharma is A3ES6P. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Medicus Pharma is MDCX. The ticker symbol is used to trade Medicus Pharma shares on the stock exchange.

Fair ValueTerminal
3.05 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Country
Currency
USD
Initial public offering
Oct 11, 2023
ISIN
CA58471K2020
Cusip
58471K103
Market capitalization
81.61 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-6.03
P/Ee 2027
-11.11
P/Ee 2028
-7.85
P/Ee 2029
325.00
P/Ee 2030
5.73
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
26.03
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-645.77 %
Last updated Oct 19, 2026, 2:23 AM

Medicus Pharma Peer Group

All fundamentals and in-depth analysis of Medicus Pharma

Our stock analysis for Medicus Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medicus Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.